Welcome to our dedicated page for Bion Environment SEC filings (Ticker: BNET), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SEC filings for Bion Environmental Technologies provide insights into the company's business operations, technology development progress, commercial deployments, financial performance, and strategic initiatives. As an OTC-traded company, Bion files periodic reports that detail operational developments, risk factors, and financial results for investors evaluating the agricultural waste treatment and resource recovery sector.
Quarterly and annual reports (10-Q and 10-K filings) describe Bion's business strategy, technology platform, target markets, competitive landscape, and progress toward commercialization. These filings include management's discussion of challenges facing the company, including technology scale-up, customer acquisition, financing requirements, and regulatory developments. Financial statements reveal revenue from technology deployments, research and development expenses, operating costs, and the company's capital structure. Risk factor disclosures address technology adoption challenges, market acceptance, competition, regulatory changes, and financial sustainability.
8-K current reports disclose material events such as commercial agreements, project milestones, changes in corporate governance, financing transactions, and operational updates. These filings provide timely information about developments that may affect the company's business prospects and stock valuation. For technology companies like Bion transitioning from development to commercial deployment, current reports offer insights into the pace of customer adoption and revenue generation.
Investors analyzing Bion's SEC filings can track the company's progress in deploying Gen3Tech systems at commercial scale, evaluate financial metrics related to technology installations, and assess management's outlook for the agricultural waste treatment market. Patent filings referenced in SEC documents reveal the scope of intellectual property protection for the company's Ammonia Recovery System and related technologies. Filings also provide context on industry trends affecting demand for environmental technologies in agriculture, including regulatory developments and sustainability initiatives within the food supply chain.
Bion Environmental Technologies, Inc. reported that on January 8, 2026, the Bion Loan Group extended the maturity date of its Convertible Promissory Note’s Second Forbearance Agreement. The agreement, which had previously moved the note’s maturity to January 15, 2026, is now extended under the same terms and conditions, including the collateral sharing agreement, until June 30, 2026.
This change gives Bion additional time before the convertible note becomes due while keeping all existing obligations and collateral arrangements in place.
Bion Environmental Technologies, Inc. has amended the timing of key debt obligations. All holders of its Secured Convertible Promissory Notes and its May 2024 Convertible Promissory Notes, which previously had a maturity date of December 31, 2025, have agreed to extend the maturity date to June 30, 2026. The notes continue under the same terms, changing only the repayment date and giving the company additional time before these convertible debts come due.
Bion Environmental Technologies, Inc. announced that it has entered into a Memorandum of Understanding (MOU) with Kimmeridge Energy Management, LLC to explore using Bion’s ammonia recovery technology at a large renewable natural gas (RNG) facility. The MOU lays out a preliminary framework for potential collaboration and is described as part of Bion’s broader business plan.
As part of the MOU, Bion granted Kimmeridge a limited right of first refusal on a 10 million share equity investment in Bion during the evaluation period, at a price set at a premium to the current market price. If the contemplated joint venture proceeds on the anticipated timelines, active development of a potential RNG facility could begin in the second quarter of 2026. The full MOU, with one immaterial redacted section, and the related press release are attached as exhibits.
Bion Environmental Technologies (BNET) filed its Q1 FY2026 10‑Q, reporting a net loss of $581,329 on zero revenue. Operating expenses were $476,547 and interest expense was $104,791, narrowing the loss from $1,171,636 a year ago.
The company disclosed substantial doubt about its ability to continue as a going concern. Cash was $27,689 against current liabilities of $5,960,528, and total stockholders’ deficit was $5,905,960. Net cash used in operations was $248,217, offset by $271,465 from financing activities.
Management shifted focus to faster‑to‑deploy, bolt‑on ammonia recovery (ARS) projects for industrial biogas facilities and plans to raise $3,000,000 to $10,000,000, plus about $8,000,000 in project financing per initial ARS project. To bridge liquidity, Bion raised $816,000 in shareholder notes and has a BLG secured note bearing 9% interest, maturing January 15, 2026.
Capital structure was simplified via September 2025 settlements that issued 8,101,746 common shares and eliminated instruments that could have added up to 22,498,405 shares, a net reduction of about 14,369,659 fully diluted shares. As of November 1, 2025, common shares outstanding were 56,891,856.
Bion Environmental Technologies (BNET) reported continued pre-revenue operations with substantial research-and-development activity focused on fertilizer, water reuse and renewable energy applications of its ARS/Gen3Tech platform. The company holds multiple issued patents and pending applications related to recovering ammonium compounds from wastewater, and states R&D results have supported its objectives. Financially, Bion recorded a large non-cash impairment that reduced shareholders' equity and produced substantial historical losses. The filing discloses limited liquidity, numerous convertible notes and shareholder loans secured by the company’s intellectual property, extensions/forbearance agreements tied to future capital raises, and material risk factors including thin trading, potential dilution, project financing needs, and cybersecurity exposure.